I can get rich by brushing my emotions

Soon, an executive named Luo Zhiwei raised his hand and said:

"Mr. Yuan, I personally think that we don't have to make trouble in the acquisition of pharmaceutical factories. We might as well try a different way of thinking."

Yuan Ze asked curiously, "Oh? What idea?"

Luo Zhiwei said seriously: "The current pharmaceutical industry, after capitalization, is relatively open on the whole. In addition to self-research, self-production, and self-sales, it can also take the CXO route, that is, pharmaceutical outsourcing.

In this field, drug R&D outsourcing and production outsourcing are relatively mature, especially some domestic CXO leaders have industrialized these things.

For example, Kangde has formed an integrated service in the fields of CRO (pharmaceutical R&D outsourcing), CMO (pharmaceutical contract manufacturing) and CDMO (pharmaceutical contract manufacturing), and is still very trustworthy.

Many start-up pharmaceutical companies are basically taking the route of outsourcing in order to reduce the cost of R&D and production. "

What Luo Zhiwei said is not nonsense, it belongs to the current trend of the times.

Even in the pharmaceutical sector of Big A, the growth rate of the CXO sector has been at the forefront of the growth rate of the entire pharmaceutical industry in recent years.

It can be seen that many pharmaceutical companies are indeed taking this path.

The second is Hongbo Medicine. The company’s main business has two major business segments. The first segment mainly includes pharmaceutical preparations, traditional Chinese medicine decoction pieces, and distribution of pharmaceutical and medicinal materials. The second segment is pharmaceutical OEM, which mainly accepts various tablets, OEM production of capsules and granules.

Don't underestimate the 2.68% increase. Based on his HK$8.337 million principal, it is equivalent to earning more than 2000 million Hong Kong dollars in vain.

After the last cooperation between Yuan Ze and Kang Lei and Hu Xu ended, a full 5.6 million RMB was transferred to the account of Yuanlai Investment Company.

But its biggest disadvantage is that handing over one's core technology to others is still the kind of willingness, begging to be handed over to others.

However, Xindongfang Online did bring Yuan Ze a considerable amount of income this time. The profit was 6.95 million Hong Kong dollars, converted into RMB, which was more than 6 million yuan.

As a result, more than half a month ago, when Yuan Ze exchanged Hong Kong dollars, the RMB/Hong Kong dollar exchange rate was still around 1.156.

Investing and building a factory by yourself is the most cost-effective, but the time cost will be greatly increased. For us, time is obviously more precious at present.

In addition, due to the recent strengthening of the U.S. dollar, the Hong Kong dollar pegged to the U.S. dollar has also begun to appreciate, which corresponds to the depreciation of the RMB.

Yuan Ze didn't dare to hand over the explosive new drug, Fat-Reducing Ling, which can effectively reduce fat and improve diabetes, to others for OEM production, so he had to take it into his own hands.

Shen Xinyao looked at the account income on the phone screen, her eyes were watery, and her heart was full of joy.

Maybe it will be the same as the chip at that time, and I have not mastered the core manufacturing technology. Once someone else gets stuck, it will be troublesome. "

Once the drug Jianfaling is launched, it will be mainly in the form of capsules.

However, with the development of the company during this period, various expenses have increased sharply. In addition, Yuan Ze has embezzled tens of millions to speculate in foreign exchange. As a result, the current available funds in the company have almost fallen below 4 million.

As for Shen Xinyao...

"President Zhan and I thought about going together. Our original intention to buy a pharmaceutical company was to acquire its pharmaceutical factory, but the main business was secondary.

Zhan Ping replied: "Among the three pharmaceutical companies, Baihua Pharmaceutical has the lowest quotation, but judging from its industrial structure and factory conditions, it is the most inconsistent with the products we will manufacture next. You can ignore this pharmaceutical company. .

That is to say, he earned 20.05 Hong Kong dollars per share by operating Xindongfang Online this time, with a base rate of return of 126.9% and a leverage ratio of four times.

But by this time, the exchange rate had already dropped to 1.125. In other words, even if Yuan Ze didn't do anything, the value increased by 2.68% out of thin air.

I just looked at the revenue of Hongbo Pharmaceutical Company, about 80% of which come from pharmaceutical OEMs, and almost all of the drugs produced are tablets, capsules and granules.

Zhan Ping took over and said: "The starting point of Manager Luo's suggestion is correct. If our company wants to develop generic drug business, because it does not involve core technology and the patent has expired, it is no problem to take the CXO route. "

Mr. Yuan, this is the information about these three companies collected and sorted out by my people. Please have a look. "

This amount of money is definitely not enough to buy Hongbo Pharmaceutical Company.

The large sums of dollars in the foreign exchange account are not mentioned.

In addition, Chengda Pharmaceutical has outsourced a good part of its medicines. Currently, there is only one pharmaceutical factory in its own right, and the output is not much. It is rather tasteless to us, so we don’t need to look at it.

Yuan Ze waved his hand and said with a smile: "It's okay, if you have any point of view, you can boldly express it, let's discuss it together, if it is wrong, deny it, but if it is right, then adopt it.

Among them, Ou Lin earned 3000 million yuan with a principal of 1.36 million yuan. She was ecstatic, but also transferred 7000 million yuan to Yuan Ze as soon as the funds were available, and kept 6600 million yuan for herself.

"I totally agree with Mr. Zhan's words." Luo Zhiwei quickly replied, and said with a smile: "I just took it for granted and didn't think it through. Mr. Yuan, Mr. Zhan, you two just think my words are farting."

At this moment, Zhan Ping looked at Ding Junbo and asked, "Manager Ding, tell me about the local pharmaceutical companies in Jiangcheng that are going to be packaged and sold. What are their quotations?"

Yuan Ze didn't refuse, and kept it.

Finally, three days later, at 9:8 pm on September 3th, before the Hong Kong stock market closed, Yuan Ze threw out all the chips he held in Xindongfang Online.

When the market was closed at noon today, she received news from Yuan Ze that she could liquidate Xindongfang Online. Without further ado, she asked for a leave of absence, returned home non-stop, and waited for the opening of the market.

On the 7th, Ou Lin and Su Yinuo were informed that they could leave depending on the situation.

Without smashing the market, he still chose the gentle way of pulling up and shipping at the same time.

After Zhan Ping finished reading it, Yuan Ze asked him for his opinion.

However, Yuan Ze said with a smile at this time: "Don't worry about money matters, I will take care of it.

However, Yuan Ze didn't quite agree with this. He chuckled and said, "Pharmaceutical outsourcing is indeed very worry-free and trouble-free in the early stage. I also know that a leading listed company in the big A medical service sector has a worthy reputation." trusted.

Follow the rules, Yuan Ze understands, he can obey the rules now.

It doesn't matter if you can't keep it down, if you can negotiate to pay in two or three installments, then there is room for buffering. "

Therefore, Hongbo Pharmaceutical Company is naturally the first choice among the three pharmaceutical companies.

"President Yuan is right." On the side, Zhan Ping nodded upon hearing the words.

According to the information given by Ding Junbo just now, Hongbo Pharmaceutical Company has three self-owned pharmaceutical factories, and the production capacity of capsule products far exceeds that of Baihua Pharmaceutical and Chengda Pharmaceutical.

In addition to clearing the warehouse and leaving, Yuan Ze naturally did not forget to inform Ou Lin and the girls.

Zhan Ping nodded and said, "Good Mr. Yuan."

In a boudoir full of fragrance and warm furnishings.

"Tell them about their main business."

According to the future trend chart in Baobao's warehouse, he can clearly see the future trend of Xindongfang Online. When the stock price of the stock reaches his psychological price of HK$35, he starts the long road to shipment.

Through the foreign exchange settlement business of DBS Bank, the 8.337 million Hong Kong dollars in Yuan Ze's Hong Kong stock account were quickly settled into 7.41 million RMB.

But the current market structure is changing every day, and globalization is also facing disintegration. No one knows what the future will look like.

He himself agrees with Yuan Ze's point of view very much. Although medical outsourcing seems to be a trend at present, many pharmaceutical companies are moving closer to this aspect.

Therefore, I personally think that Hongbo Medicine, which is engaged in the pharmaceutical OEM business, is more suitable for our company. "

After a few gossips, Yuan Ze continued:
"Okay, let's get back to the topic, the new drugs we are going to produce next cannot be outsourced, and we have to firmly control them in our own hands, so we either build our own factories for R&D and production, or buy existing pharmaceutical factories to do it.

However, on the issue of medical outsourcing, I agree with Mr. Zhan.

"Okay." Ding Junbo hurriedly found a document from the table, read it and said:

The average selling price was HK$35.85, while his opening price was only HK$15.8.

There is really no need to worry too much about the acquisition of funds for pharmaceutical companies.

Due to the increased leverage, both of their earnings this time were more than 4 times.

So, the next two days.

Therefore, the cost and expenditure of some things cannot be saved. "

In the end, after deducting all transaction costs, he made a profit of 6.95 million Hong Kong dollars in Xindongfang Online this time. Adding the original deposit, the total principal amount reached 8.337 million Hong Kong dollars.

Compared with the above two companies, Chengda Pharmaceutical's main business is broader, covering chemical pharmaceuticals, pharmaceutical commerce, pharmaceutical engineering, biomedicine and other sectors. The company's main products include vitamin products, anti-infection products, reproductive Systemic and sex hormone products, digestive tract products... The company currently has more than 50 kinds of chemical raw materials, pharmaceutical intermediates and preparation products.

Moreover, handing over our own research and development and production links to others means that whether we can survive well has nothing to do with our own efforts, but depends on the conscience and agreement of others.

"In terms of main business, first of all is Baihua Pharmaceutical, which is mainly engaged in the research and development, production, sales of medicines and health food, as well as medical and health services such as medical diagnosis, gene preservation, and pregnancy environment monitoring.

At this point, Ding Junbo hastily handed over the document in his hand to Yuan Ze.

"However, Mr. Yuan, the quotation from Hongbo Pharmaceutical Company is 12.5 billion yuan. This is not a small amount. Our company can't afford so much money at present..." Zhan Ping reminded.

As for the Hong Kong stock account alone, the current profit brought to him by Xindongfang Online stock has exceeded 5 million Hong Kong dollars.

Yuan Ze finally read the documents for a while, then handed the documents to Zhan Ping.

Although Su Yinuo didn't make as much money as Ou Lin this time, she made 120 million yuan with a principal of just over 550 million yuan. She couldn't help but call herself rich.

……

Regardless of the convenience and hassle of CRO and CDMO, they can even save a lot of extra costs.But as far as I know, there are quite a few lawsuits every year because of the patent issue of the original research drug.

Yuan Ze's mind was focused on making money, and his main goal was naturally to clear the warehouse of Xindongfang Online.

After all, once the interests involved are large enough, someone will always dare to break the rules of the game. "

Because the villains have grown up to be more disguised and smarter.

Judging from the historical development and changes in the past few thousand years, as long as the interests are large enough, there is nothing that human beings dare not do.

……

Ding Junbo hurriedly said: "According to my data, there are three pharmaceutical companies that are willing to package their main business and sell them together with pharmaceutical factories, namely Baihua Pharmaceutical, Hongbo Pharmaceutical and Chengda Pharmaceutical. The quotations are 8.6 million yuan in order , 12.5 billion yuan, 23.8 billion yuan."

Yuan Ze restrained his smile and said seriously: "I don't deny that the pharmaceutical outsourcing route can promote the optimization of the overall pharmaceutical industry structure, but that's not the way we want to go, at least not now.

This has a great overlap with the second half of the manufacturing process of the fat-reducing spirit that our company will produce next. "

Of the two sums of money, one was used to repay the 5700 million yuan borrowed by Yuan Zewen's company before, and the other was used to borrow 6.43 million yuan to the company in the form of a loan.

The present era is a good era, but it is also an era in which we should be most vigilant and speculate on others with the greatest malice.

After leaving a fraction of 4100 million yuan for himself, the bulk of 7 million yuan was divided into two sums and transferred to the account of Yuanlai Investment Company.

The current Yuan Ze is not what it used to be, and there is no need to worry about more than one billion RMB.

After speaking, Zhanping paused, and then said in a deep voice: "However, the drugs our company is currently developing are new drugs and original research drugs developed by ourselves, so we must not take the CXO route.

Yuan Ze nodded approvingly when he heard this:

In this way, Yuan Ze formed a loan relationship with the company, and if he misappropriated money from the company in the future, as long as the accountant was properly accounted for, it could be said to be borrowing money or asking for an account, rather than some illegal embezzlement.

Perhaps many pharmaceutical companies feel that pharmaceutical outsourcing is a major trend and can be pursued, but that is someone else's business. "

So, after all, we still have to buy a suitable pharmaceutical factory. If it doesn't work, we can buy a whole pharmaceutical company directly. "

Tearing up agreements, changing orders day and night, going back on what they said, ignoring the facts, telling lies... These things are often seen even now.

Of course, the RMB/Hong Kong dollar is just a small fight, and the pound/dollar held in the foreign exchange accounts of Yuan Ze, Kang Lei and others is the main battlefield.

Mr. Zhan, you should first send someone to contact the people of Hongbo Pharmaceutical Company, and have a good talk with them to see if you can lower the price again.

After the market opened, seeing that the stock price was still going up, she waited and waited until it couldn't rise before she began to sell a little bit.

She has been watching the market all afternoon, and since Xindongfang Online is in a good mood today, her selling position is actually very good.

On average, the selling price was more than 36 Hong Kong dollars, which was higher than Yuan Zedu.

After deducting miscellaneous expenses, her operating rate of return this time is as high as 5 times, and her profit is 1125 million RMB.

……